RE:RE:Jap dealTrue, is it possible the company wanted a catalyst closing in on the ADCOM. We are a lot closer to not requiring a consolidation and a much more expensive take out. Berandt has played it pretty much perfectly so far and I'm thinking he has all moves and timing worked out. A positive ADCOM doubles us again and puts us on a run to the FDA approval.
Its going to be real exciting, hold on to your shorts.